MiR-146b-5p targets IFI35 to inhibit inflammatory response and apoptosis via JAK1/STAT1 signalling in lipopolysaccharide-induced glomerular cells

References

• Kaul A, Gordon C, Crow MK, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.
   PubMed Web of Science ®Google Scholar
• Durcan L, O'Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet. 2019;393(10188):2332–2343.
   PubMed Web of Science ®Google Scholar
• Mohan C, Putterman C. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol. 2015;11(6):329–341.
   PubMed Web of Science ®Google Scholar
• Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–835.
   PubMed Web of Science ®Google Scholar
• Dai XG, Li Q, Li T, et al. The interaction between C/EBPβ and TFAM promotes acute kidney injury via regulating NLRP3 inflammasome-mediated pyroptosis. Mol Immunol. 2020;127:136–145.
   PubMed Web of Science ®Google Scholar
• Soni C, Sinha I, Fasnacht MJ, et al. Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice. Autoimmunity. 2019;52(2):57–68.
   PubMed Web of Science ®Google Scholar
• Hao Y, Li H, Li Y, et al. Decreased TLR4 expression on monocytes may cause regulatory T cells abnormality in patients with primary immune thrombocytopenia. Autoimmunity. 2017;50(5):283–292.
   PubMed Web of Science ®Google Scholar
• Peng X, Yang T, Liu G, et al. Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome. Int Immunopharmacol. 2018;65:448–457.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li H. Alkannin protects human renal proximal tubular epithelial cells from LPS-induced inflammatory injury by regulation of microRNA-210. Biomed Pharmacother. 2018;108:1679–1685.
   PubMed Web of Science ®Google Scholar
• Zhao H, Ma SX, Shang YQ, et al. microRNAs in chronic kidney disease. Clin Chim Acta. 2019;491:59–65.
   PubMed Web of Science ®Google Scholar
• Schwartz N, Goilav B, Putterman C. The pathogenesis, diagnosis and treatment of lupus nephritis. Curr Opin Rheumatol. 2014;26(5):502–509.
   PubMed Web of Science ®Google Scholar
• Sole C, Moline T, Vidal M, et al. An exosomal urinary miRNA signature for early diagnosis of renal fibrosis in lupus nephritis. Cells. 2019;8(8):773.
   Web of Science ®Google Scholar
• Nakhjavani M, Etemadi J, Pourlak T, et al. Plasma levels of miR-21, miR-150, miR-423 in patients with lupus nephritis. Iran J Kidney Dis. 2019;13(3):198–206.
   PubMed Web of Science ®Google Scholar
• Hulsmans M, Van Dooren E, Mathieu C, et al. Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectin. PLoS One. 2012;7(2):e32794.
   PubMed Web of Science ®Google Scholar
• Lin N, An Y. Blockade of 146b-5p promotes inflammation in atherosclerosis-associated foam cell formation by targeting TRAF6. Exp Ther Med. 2017;14(5):5087–5092.
   PubMed Web of Science ®Google Scholar
• Chen P, Li Y, Li L, et al. Circulating microRNA146b-5p is superior to C-reactive protein as a novel biomarker for monitoring inflammatory bowel disease. Aliment Pharmacol Ther. 2019;49(6):733–743.
   PubMed Web of Science ®Google Scholar
• Sheng ZX, Yao H, Cai ZY. The role of miR-146b-5p in TLR4 pathway of glomerular mesangial cells with lupus nephritis. Eur Rev Med Pharmacol Sci. 2018;22(6):1737–1743.
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Yano C, Numata A, et al. Interferon (IFN)-induced protein 35 (IFI35), a type I interferon-dependent transcript, upregulates inflammatory signaling pathways by activating toll-like receptor 3 in human mesangial cells. Kidney Blood Press Res. 2016;41(5):635–642.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu H, Li Y, et al. The role of IFI35 in lupus nephritis and related mechanisms. Mod Rheumatol. 2017;27(6):1010–1018.
   PubMed Web of Science ®Google Scholar
• Yeung YT, Aziz F, Guerrero-Castilla A, et al. Signaling pathways in inflammation and anti-inflammatory therapies. Curr Pharm Des. 2018;24(14):1449–1484.
   PubMed Web of Science ®Google Scholar
• Ivashkiv LB. Type I interferon modulation of cellular responses to cytokines and infectious pathogens: potential role in SLE pathogenesis. Autoimmunity. 2003;36(8):473–479.
   PubMed Web of Science ®Google Scholar
• Lin YZ, Li RN, Lin CH, et al. Association of OSMR gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus patients. Autoimmunity. 2014;47(1):23–26.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Flores-Mendoza G, Sanson SP, Rodriguez-Castro S, et al. Mechanisms of tissue injury in lupus nephritis. Trends Mol Med. 2018;24(4):364–378.
   PubMed Web of Science ®Google Scholar
• Paterson MR, Geurts AM, Kriegel AJ. miR-146b-5p has a sex-specific role in renal and cardiac pathology in a rat model of chronic kidney disease. Kidney Int. 2019;96(6):1332–1345.
   PubMed Web of Science ®Google Scholar
• Kaser A, Tilg H. Novel therapeutic targets in the treatment of IBD. Expert Opin Ther Targets. 2008;12(5):553–563.
   PubMed Web of Science ®Google Scholar
• Perrier C, Rutgeerts P. Cytokine blockade in inflammatory bowel diseases. Immunotherapy. 2011;3(11):1341–1352.
   PubMed Web of Science ®Google Scholar
• Nagata S. Apoptosis and clearance of apoptotic cells. Annu Rev Immunol. 2018;36:489–517.
   PubMed Web of Science ®Google Scholar
• Strasser A, Vaux DL. Viewing BCL2 and cell death control from an evolutionary perspective. Cell Death Differ. 2018;25(1):13–20.
   PubMed Web of Science ®Google Scholar
• Alanazi I, Hoffmann P, Adelson DL. MicroRNAs are part of the regulatory network that controls EGF induced apoptosis, including elements of the JAK/STAT pathway, in A431 cells. PLoS One. 2015;10(3):e0120337.
   PubMed Web of Science ®Google Scholar
• Liu T, Li C, Jin L, et al. The prognostic value of m6A RNA methylation regulators in colon adenocarcinoma. Med Sci Monit. 2019;25:9435–9445.
   PubMed Web of Science ®Google Scholar
• Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. 2015;16(7):421–433.
   PubMed Web of Science ®Google Scholar
• Jia M, Shi Y, Li Z, et al. MicroRNA-146b-5p as an oncomiR promotes papillary thyroid carcinoma development by targeting CCDC6. Cancer Lett. 2019;443:145–156.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang J, Fu Z, et al. Sevoflurane suppresses migration and invasion of glioma cells by regulating miR-146b-5p and MMP16. Artif Cells Nanomed Biotechnol. 2019;47(1):3306–3314.
   PubMed Web of Science ®Google Scholar
• Chen J, Naumovski L. Intracellular redistribution of interferon-inducible proteins Nmi and IFP 35 in apoptotic cells. J Interferon Cytokine Res. 2002;22(2):237–243.
   PubMed Web of Science ®Google Scholar
• Rebane A, Zimmermann M, Aab A, et al. Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J Allergy Clin Immunol. 2012;129(5):1297–1306.
   PubMed Web of Science ®Google Scholar
• Castejon ML, Sanchez-Hidalgo M, Aparicio-Soto M, et al. Dietary oleuropein and its new acyl-derivate attenuate murine lupus nephritis through HO-1/Nrf2 activation and suppressing JAK/STAT, NF-κB, MAPK and NLRP3 inflammasome signaling pathways. J Nutr Biochem. 2019;74:108229.
   PubMed Web of Science ®Google Scholar
• Gadina M, Johnson C, Schwartz D, et al. Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs. J Leukoc Biol. 2018;104(3):499–514.
   PubMed Web of Science ®Google Scholar
• Sanpaolo ER, Rotondo C, Cici D, et al. JAK/STAT pathway and molecular mechanism in bone remodeling. Mol Biol Rep. 2020;47(11):9087–9096.
   PubMed Web of Science ®Google Scholar
• Nabavi SM, Ahmed T, Nawaz M, et al. Targeting STATs in neuroinflammation: the road less traveled!. Pharmacol Res. 2019;141:73–84.
   PubMed Web of Science ®Google Scholar
• Moshapa FT, Riches-Suman K, Palmer TM. Therapeutic targeting of the proinflammatory IL-6-JAK/STAT signalling pathways responsible for vascular restenosis in type 2 diabetes mellitus. Cardiol Res Pract. 2019;2019:9846312.
   PubMed Web of Science ®Google Scholar
• Alunno A, Padjen I, Fanouriakis A, et al. Pathogenic and therapeutic relevance of JAK/STAT signaling in systemic lupus erythematosus: integration of distinct inflammatory pathways and the prospect of their inhibition with an oral agent. Cells. 2019;8(8):898.
   PubMed Web of Science ®Google Scholar
• Dong J, Wang QX, Zhou CY, et al. Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice. Lupus. 2007;16(2):101–109.
   PubMed Web of Science ®Google Scholar
• Wang S, Yang N, Zhang L, et al. Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice. Lupus. 2010;19(10):1171–1180.
   PubMed Web of Science ®Google Scholar
• Kutty RK, Nagineni CN, Samuel W, et al. Differential regulation of microRNA-146a and microRNA-146b-5p in human retinal pigment epithelial cells by interleukin-1beta, tumor necrosis factor-alpha, and interferon-gamma. Mol Vis. 2013;19:737–750.
   PubMed Web of Science ®Google Scholar